Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Queensland Health
Accenture
Deloitte
Fuji
Cerilliant
Moodys
Argus Health
Boehringer Ingelheim

Generated: November 15, 2018

DrugPatentWatch Database Preview

Panitumumab - Biologic Drug Details

« Back to Dashboard

Summary for panitumumab
Tradenames:1
Patents:221
Applicants:1
BLAs:1
Suppliers: see list1
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for panitumumab
Pharmacology for panitumumab
Ingredient-typeAntibodies, Monoclonal
Mechanism of ActionHER1 Antagonists

US Patents for panitumumab

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 001 2006-09-27 ➤ Try a Free Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) ➤ Try a Free Trial RX search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 001 2006-09-27 ➤ Try a Free Trial VentiRx Pharmaceuticals, Inc. (Seattle, WA) ➤ Try a Free Trial RX search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 001 2006-09-27 ➤ Try a Free Trial University of Georgia Research Foundation, Inc. (Athens, GA) ➤ Try a Free Trial RX search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 001 2006-09-27 ➤ Try a Free Trial Roche Molecular Systems, Inc. (Pleasanton, CA) ➤ Try a Free Trial RX search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 001 2006-09-27 ➤ Try a Free Trial AMGEN, INC (Thousand Oaks, CA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for panitumumab

Supplementary Protection Certificates for panitumumab

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2008001 Lithuania ➤ Try a Free Trial PRODUCT NAME: PANITUMUMABUM; REGISTRATION NO/DATE: ANUM>EU/1/07/423/001-003 20071203
C/GB08/009 United Kingdom ➤ Try a Free Trial PRODUCT NAME: PANITUMUMAB; REGISTERED: UK EU/1/07/423/001 20071205; UK EU/1/07/423/002 20071205; UK EU/1/07/423/003 20071205
C005/2008 Ireland ➤ Try a Free Trial SPC005/2008: 20081105, EXPIRES: 20221202
C0006 France ➤ Try a Free Trial PRODUCT NAME: PANITUMUMAB; REGISTRATION NO/DATE: EU/1/07/423/001 20071203
2008000009 Germany ➤ Try a Free Trial PRODUCT NAME: PANITUMUMAB; REGISTRATION NO/DATE: EU/1/07/423/001-003 20071203
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cantor Fitzgerald
Boehringer Ingelheim
Baxter
AstraZeneca
Fish and Richardson
QuintilesIMS
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.